The agreement with Algen Biotechnologies gives AstraZeneca exclusive rights to develop and commercialise therapies from the ...

AstraZeneca has signed a $555 million deal with a San Francisco-based biotech business Algen Biotechnologies, The Financial Times reported on Monday. The agreement with Algen gives AstraZeneca ...

Treatment introduces an expansion of the scope of gene therapies that might lead to similar treatments for neurodegenerative ...

A gene-editing tool that can turn genes on and off like a light switch has been developed. Turning a gene on means activating the production of ...

A gene-editing therapy led to durable changes in serum transthyretin levels among people with hereditary transthyretin ...

EXTON, PA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- As the first wave of gene therapies for transfusion-dependent β-thalassemia (TDT) continues to roll out in the U.S., a new conversation is emerging within ...

Turning genes on and off is like flipping a light switch, controlling whether genes in a cell are active. When a gene is ...

Cayman Chemical, a global provider of life science research tools, and Akadeum Life Sciences, a leader in buoyancy-based cell ...

The inaugural Genetic Agency Technology Conference (GATC) on November 11th, 2025 will convene technical thought leaders, gene therapy developers, patients, their families, and patient advocates across ...

Founded in 2020 by Chilean biochemist Bernardo Pollak, Meristem is using precise gene editing techniques to develop local ...

In a development that could help protect one of the world's most beloved agricultural commodities, a research team at Penn ...

Genetic sequencing has gone through several advances. A major breakthrough came when scientists began breaking the billions of letters that compose DNA up into relatively small bits of a few hundred ...